PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Breakthrough in proton barrier films using pore-free graphene oxide

Kumamoto University researchers achieve new milestone in advanced coating technologies

Breakthrough in proton barrier films using pore-free graphene oxide
2024-09-13
(Press-News.org)

Kumamoto University’s research team, led by Assistant Professor Kazuto Hatakeyama and Professor Shintaro Ida of Institute of Industrial Nanomaterials, has announced a groundbreaking development in hydrogen ion barrier films using graphene oxide (GO) that lacks internal pores. This innovative approach promises significant advancements in protective coatings for various applications.

 

In their study, the research team successfully synthesized and developed a thin film from a new form of graphene oxide that does not contain pores. Traditionally, GO has been known for its high ionic conductivity, which made it challenging to use as an ion barrier. However, by eliminating the internal pores, the team created a material with dramatically improved hydrogen ion barrier properties.

 

The new graphene oxide film exhibits up to 100,000 times better hydrogen ion barrier performance compared to conventional GO films, based on the AC impedance spectroscopy ‘s out-of-plane proton conductivity result. This breakthrough has also been demonstrated through experiments where the non-porous graphene oxide coating effectively protected lithium foil from water droplets, preventing any reaction between the lithium and the water.

 

The study also confirmed that hydrogen ions move through the pores in conventional GO, highlighting the significance of eliminating these pores to enhance barrier capabilities. This advancement opens doors to new applications in protective coatings, rust prevention, and hydrogen infrastructure.

 

This research marks a significant advance in materials science and could pave the way for next-generation coatings with enhanced protective properties. "Moving forward, we plan to harness the hydrogen ion barrier performance for practical applications, while also addressing the challenges posed by the 'pores' in the GO structure to unlock additional functionalities," explained Assistant Professor Hatakeyama as he outlined the next steps in his research.

END


[Attachments] See images for this press release:
Breakthrough in proton barrier films using pore-free graphene oxide Breakthrough in proton barrier films using pore-free graphene oxide 2

ELSE PRESS RELEASES FROM THIS DATE:

Urbanization has impacted the population genetic structure of the Eurasian red squirrel in Japan within a short period of 30 years

Urbanization has impacted the population genetic structure of the Eurasian red squirrel in Japan within a short period of 30 years
2024-09-13
Since many kinds of wildlife have started living in urban environments, urban environments have been recognized as places of biodiversity conservation. What kind of factors facilitate or prohibit wildlife from living in urban environments? Understanding the population genetic structure of urban wildlife living would suggest the hint. In this study, we investigated the population genetic structure of Eurasian red squirrels living in urban to rural areas in Obihiro City, Hokkaido, Japan. As a result, we found that ...

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

2024-09-13
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is targeted for patients with lung cancer, melanoma and other solid tumours. Nineteen patients with advanced stage cancers received between one and nine doses of the immunotherapy treatment. Scientists have found the immunotherapy created an immune response against cancer and was well tolerated, with adverse events ...

Rapid new blood diagnostic test for ALS

Rapid new blood diagnostic test for ALS
2024-09-13
(Jackson, Wyoming – Embargoed until Thursday 12 September 2024 8:00 PM EDT) A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that effects neurons in the brain and spinal cord.  ALS leads to gradual paralysis, ultimately resulting in the inability to walk, speak, or, in later stages, move. Currently, diagnosis is based on a thorough clinical examination, but it can take up to 12 months to provide a definitive diagnosis, by which time many patients have significantly ...

Ignore antifungal resistance in fungal disease at your peril, warn top scientists

2024-09-12
Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group of scientists from the across the world has warned. The commentary -  published in The Lancet this week - was coordinated by scientists at The University of Manchester, the Westerdijk Institute and the University of Amsterdam. According to the scientists most fungal pathogens identified by the World Health Organisation - accounting for around 3.8 million deaths a year - are either already resistant or rapidly acquiring resistance to antifungal drugs. The authors argue that the currently narrow focus on bacteria will not fully combat antimicrobial resistance ...

Increased testing for heart disease indicator needed worldwide

2024-09-12
Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested for and possibly treated. 20 % of the world population carries a genetic risk factor for cardiovascular diseases such as heart attacks, strokes, and aortic valve stenosis: Increased levels of a lipid particle called lipoprotein(a). It is the most common genetic cause of cardiovascular diseases. “Lipoprotein(a) is the direct cause of cardiovascular diseases much like cigarettes cause ...

Huge gamma-ray burst collection 'rivals 250-year-old Messier catalogue'

Huge gamma-ray burst collection rivals 250-year-old Messier catalogue
2024-09-12
Huge gamma-ray burst collection 'rivals 250-year-old Messier catalogue' Royal Astronomical Society press release RAS PR 24/24 Embargoed until 00:01 BST on Friday 13 September 2024   Hundreds of gamma-ray bursts (GRBs) have been recorded as part of an enormous global effort so extensive it "rivals the catalogue of deep-sky objects created by Messier 250 years ago", astronomers say. GRBs are the most violent explosions in the Universe, releasing more energy than the Sun would in 10 billion years. They occur when either a massive star dies or two neutron stars merge. The explosions are so ...

Crude oil decimates sea otter buoyancy

2024-09-12
 Sea otters are famed for their luscious pelts, but the fur almost led to their extinction. By 1938, only a tiny population of ~50 remained clinging to the central California coast. Since then, the mammals have battled back; however, the charismatic creatures are still at risk from crude oil spilled by offshore rigs. But no one knew how severely crude oil impacts the buoyancy of sea otter fur or how well it recovers after cleaning. And Kate Riordan from California Polytechnic State University San Luis ...

Semaglutide and tirzepatide lead to better blood sugar control and weight loss in individuals with type 1 diabetes, US study finds

2024-09-12
Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found. The two relatively new drugs are approved to treat type 2 diabetes and for weight loss. In type 2 diabetes, they help the body produce more insulin when needed. ...

Fear of hypoglycaemia remains a major barrier to exercise among adults with type 1 diabetes

2024-09-12
Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycaemia (low blood sugar) remains a significant barrier to physical activity and exercise for adults with type 1 diabetes (T1D), according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept). However, the findings suggest that if exercise and diabetes management are discussed in the clinic, this fear could be reduced. “Regular exercise can help individuals with diabetes to achieve their blood glucose goals, improve their ...

New technology ‘game changing’ for marathon runners with type 1 diabetes

2024-09-12
A series of case reports to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses informed by an insulin pump algorithm helped three adults with type 1 diabetes better manage their blood sugars enabling them to lead more active lives, and even run marathons. The AID system contains an advanced hybrid closed loop algorithm that automates the delivery of both basal and correction bolus insulin every 5 minutes based on sensor glucose values. “It is great to see advances in ...

LAST 30 PRESS RELEASES:

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

[Press-News.org] Breakthrough in proton barrier films using pore-free graphene oxide
Kumamoto University researchers achieve new milestone in advanced coating technologies